Crossmark

Tofacitinib in the treatment of moderate to severe ulcerative colitis in Colombia: Real world experience

Crossref DOI link: https://doi.org/10.1016/j.gastre.2022.10.011

Published Print: 2023-08

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Parra-Izquierdo, Viviana

Frías-Ordoñez, Juan Sebastián

Márquez, Juan Ricardo

Juliao-Baños, Fabián

Galindo, Pablo

Cuadros, Carlos

Rojas, Carlos

Rojas, Nelson

Ardila, Oscar

Tovar-Fierro, German

García-Duperly, Rafael

Vargas, Melquicedec

Flórez-Sarmiento, Cristian
License Information

Text and Data Mining valid from 2023-08-01

stm-asf valid from 2023-08-01

stm-asf valid from 2023-08-01

stm-asf valid from 2023-08-01

stm-asf valid from 2023-08-01

stm-asf valid from 2023-08-01
More Information

This article is maintained by: Elsevier

Article Title: Tofacitinib in the treatment of moderate to severe ulcerative colitis in Colombia: Real world experience

Journal Title: Gastroenterología y Hepatología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.gastre.2022.10.011

Content Type: article

Copyright: © 2022 Elsevier España, S.L.U. All rights reserved.